Park et al. pointed out that the cAMP signaling pathway inhibited the degradation of the HDAC8 and the expression of TIPRL in lung cancer cells, and also increased cisplatin-induced apoptosis [24]. This evidence concerns the gene TIPRL and lung carcinoma.